this clinical trial's aim is to compare two desensitizing agents available in the market to prove which one is more efficient in children with molar incisor hypomineralization complaining from hypersensitivity
Patients aged between 8 and 10 years old with MIH affected teeth according to European Academy of Pediatric Dentistry diagnostic criteria (Lygidakis et al., 2022)
Systemically healthy.
Cooperative patients who will comply with follow-up visits.
At least one first molar or one incisor erupted in the oral cavity exhibiting molar incisor hypomineralization.
Undergoing desensitizing treatments in the last 3 months
Occlusal problems such as bruxism.
Cognition problems.
Who used any type of analgesics before treatment.